In addition to NF-kB, survival of DLBCL cells turned out to be promoted by antiapoptotic BCL2 family members, which were targeted by genomic amplification or translocation in 17.4% of cases. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.